Адјуванс (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Адјуванс" in Serbian language version.

refsWebsite

Global rank Serbian rank

21doi.org

2^nd place

4^th place

15nih.gov

4^th place

8^th place

5semanticscholar.org

11^th place

23^rd place

2worldcat.org

5^th place

12^th place

1superbabyonline.com

low place

1archive.org

6^th place

5^th place

archive.org

Hutchison, Sharon; Benson, Robert A.; Gibson, Vivienne B.; Pollock, Abigail H.; Garside, Paul; Brewer, James M. (2012). „Antigen depot is not required for alum adjuvanticity”. The FASEB Journal. 26 (3): 1272—1279. PMC 3289510 . PMID 22106367. doi:10.1096/fj.11-184556.

doi.org

Collin, Nicolas (2013). „Modern Vaccines/Adjuvants Formulation—Session 2 (Plenary II)”. Human Vaccines & Immunotherapeutics. 9 (9): 2015—2016. PMC 3906372 . PMID 23966098. doi:10.4161/hv.26208.
Yamamoto, Rokuro (1924). „Sur les bases nouvelles de la sismophysique et sur la constitution interne du globe terrestre”. Annales de Physique. 10 (1): 293—345. ISSN 0003-4169. doi:10.1051/anphys/192410010293.
Di Pasquale, A.; Preiss, S.; Tavares Da Silva, F.; Garçon, N. (2015). „Vaccine Adjuvants: From 1920 to 2015 and Beyond”. Vaccines (Basel). 3 (2): 320—43. PMC 4494348 . PMID 26343190. doi:10.3390/vaccines3020320 .
Glenny, A. T.; Pope, C. G.; Waddington, Hilda; Wallace, U. (1926). „Immunological notes. XVII-XXIV”. Journal Pathol Bacteriol. 29 (1): 31—40. doi:10.1002/path.1700290106. .
Apostólico, Juliana de Souza; Lunardelli, Victória Alves Santos; Coirada, Fernanda Caroline; Boscardin, Silvia Beatriz; Rosa, Daniela Santoro (2016). „Adjuvants: Classification, Modus Operandi , and Licensing”. Journal of Immunology Research. 2016: 1—16. PMC 4870346 . PMID 27274998. doi:10.1155/2016/1459394 .
Ott, Gary; Van Nest, Gary (2006-11-02). „Development of Vaccine Adjuvants: A Historical Perspective”. Vaccine Adjuvants and Delivery Systems: 1—31. doi:10.1002/9780470134931.ch1.
Guy, B. (2007). „The perfect mix: Recent progress in adjuvant research”. Nat Rev Microbiol. 5 (7): 505—17. PMID 17558426. S2CID 25647540. doi:10.1038/nrmicro1681. .
Christensen, Dennis (2016). „Vaccine adjuvants: Why and how”. Hum Vaccin Immunother. 12 (10): 2709—11. PMC 5084984 . PMID 27551808. doi:10.1080/21645515.2016.1219003.
Coffman, R. L.; Sher, A.; Seder, R. A. (2010). „Vaccine adjuvants: Putting innate immunity to work”. Immunity. 33 (4): 492—503. PMC 3420356 . PMID 21029960. doi:10.1016/j.immuni.2010.10.002. .
Reed, Steven G.; Orr, Mark T.; Fox, Christopher B. (2013). „Key roles of adjuvants in modern vaccines”. Nat Med. 19 (12): 1597—608. PMID 24309663. S2CID 5360604. doi:10.1038/nm.3409. .
Oteros, J.; Bartusel, E.; Alessandrini, F.; Núñez, A.; Moreno, D. A.; Behrendt, H.; Schmidt-Weber, C.; Traidl-Hoffmann, C.; Buters, J. (2019). „Artemisia pollen is the main vector for airborne endotoxin”. Journal of Allergy and Clinical Immunology. 143 (1): 367—377. PMID 30012513. S2CID 51645690. doi:10.1016/j.jaci.2018.05.040.
Oteros, J.; Bartusel, E.; Alessandrini, F.; Núñez, A.; Moreno, D. A.; Behrendt, H.; Schmidt-Weber, C.; Traidl-Hoffmann, C.; Buters, J. (2019). „Artemisia pollen is the main vector for airborne endotoxin”. Journal of Allergy and Clinical Immunology. 143 (1): 367—377. PMID 30012513. S2CID 51645690. doi:10.1016/j.jaci.2018.05.040. .
Smith, J. W.; Fletcher, W. B.; Peters, M.; Westwood, M.; Perkins, F. J. (1975). „Response to influenza vaccine in adjuvant 65-4”. The Journal of Hygiene. 74 (2): 251—259. PMC 2130368 . PMID 1054729. doi:10.1017/S0022172400024323.
Guimarães, L. E.; Baker, B.; Perricone, C.; Shoenfeld, Y. (2015). „Vaccines, adjuvants and autoimmunity”. Pharmacological Research. 100: 190—209. PMID 26275795. doi:10.1016/j.phrs.2015.08.003. Грешка код цитирања: Неисправна ознака <ref>; назив „:22” је дефинисано више пута с различитим садржајем
Apostólico, Juliana de Souza; Lunardelli, Victória Alves Santos; Coirada, Fernanda Caroline; Boscardin, Silvia Beatriz; Rosa, Daniela Santoro (2016). „Adjuvants: Classification, Modus Operandi , and Licensing”. Journal of Immunology Research. 2016: 1—16. PMC 4870346 . PMID 27274998. doi:10.1155/2016/1459394 .
Hutchison, Sharon; Benson, Robert A.; Gibson, Vivienne B.; Pollock, Abigail H.; Garside, Paul; Brewer, James M. (2012). „Antigen depot is not required for alum adjuvanticity”. The FASEB Journal. 26 (3): 1272—1279. PMC 3289510 . PMID 22106367. doi:10.1096/fj.11-184556.
Apostólico Jde, S.; Lunardelli, V. A.; Coirada, F. C.; Boscardin, S. B.; Rosa, D. S. (2016). „Adjuvants: Classification, Modus Operandi, and Licensing”. Journal of Immunology Research. 2016: 1—16. PMC 4870346 . PMID 27274998. doi:10.1155/2016/1459394 .
Nguyen-Contant, Phuong; Sangster, Mark Y.; Topham, David J. (2021-03-17). „Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response”. Pathogens (Basel, Switzerland). 10 (3): 355. ISSN 2076-0817. doi:10.3390/pathogens10030355 .
Alving, Carl R.; Beck, Zoltan; Matyas, Gary R.; Rao, Mangala (2016). „Liposomal adjuvants for human vaccines”. Expert Opinion on Drug Delivery. 13 (6): 807—816. PMID 26866300. S2CID 30639153. doi:10.1517/17425247.2016.1151871.

dx.doi.org

Yamamoto, Rokuro (1924). „Sur les bases nouvelles de la sismophysique et sur la constitution interne du globe terrestre”. Annales de Physique. 10 (1): 293—345. ISSN 0003-4169. doi:10.1051/anphys/192410010293.
Ott, Gary; Van Nest, Gary (2006-11-02). „Development of Vaccine Adjuvants: A Historical Perspective”. Vaccine Adjuvants and Delivery Systems: 1—31. doi:10.1002/9780470134931.ch1.

nih.gov

ncbi.nlm.nih.gov

Collin, Nicolas (2013). „Modern Vaccines/Adjuvants Formulation—Session 2 (Plenary II)”. Human Vaccines & Immunotherapeutics. 9 (9): 2015—2016. PMC 3906372 . PMID 23966098. doi:10.4161/hv.26208.
Di Pasquale, A.; Preiss, S.; Tavares Da Silva, F.; Garçon, N. (2015). „Vaccine Adjuvants: From 1920 to 2015 and Beyond”. Vaccines (Basel). 3 (2): 320—43. PMC 4494348 . PMID 26343190. doi:10.3390/vaccines3020320 .
Apostólico, Juliana de Souza; Lunardelli, Victória Alves Santos; Coirada, Fernanda Caroline; Boscardin, Silvia Beatriz; Rosa, Daniela Santoro (2016). „Adjuvants: Classification, Modus Operandi , and Licensing”. Journal of Immunology Research. 2016: 1—16. PMC 4870346 . PMID 27274998. doi:10.1155/2016/1459394 .
Guy, B. (2007). „The perfect mix: Recent progress in adjuvant research”. Nat Rev Microbiol. 5 (7): 505—17. PMID 17558426. S2CID 25647540. doi:10.1038/nrmicro1681. .
Christensen, Dennis (2016). „Vaccine adjuvants: Why and how”. Hum Vaccin Immunother. 12 (10): 2709—11. PMC 5084984 . PMID 27551808. doi:10.1080/21645515.2016.1219003.
Coffman, R. L.; Sher, A.; Seder, R. A. (2010). „Vaccine adjuvants: Putting innate immunity to work”. Immunity. 33 (4): 492—503. PMC 3420356 . PMID 21029960. doi:10.1016/j.immuni.2010.10.002. .
Reed, Steven G.; Orr, Mark T.; Fox, Christopher B. (2013). „Key roles of adjuvants in modern vaccines”. Nat Med. 19 (12): 1597—608. PMID 24309663. S2CID 5360604. doi:10.1038/nm.3409. .
Oteros, J.; Bartusel, E.; Alessandrini, F.; Núñez, A.; Moreno, D. A.; Behrendt, H.; Schmidt-Weber, C.; Traidl-Hoffmann, C.; Buters, J. (2019). „Artemisia pollen is the main vector for airborne endotoxin”. Journal of Allergy and Clinical Immunology. 143 (1): 367—377. PMID 30012513. S2CID 51645690. doi:10.1016/j.jaci.2018.05.040.
Oteros, J.; Bartusel, E.; Alessandrini, F.; Núñez, A.; Moreno, D. A.; Behrendt, H.; Schmidt-Weber, C.; Traidl-Hoffmann, C.; Buters, J. (2019). „Artemisia pollen is the main vector for airborne endotoxin”. Journal of Allergy and Clinical Immunology. 143 (1): 367—377. PMID 30012513. S2CID 51645690. doi:10.1016/j.jaci.2018.05.040. .
Smith, J. W.; Fletcher, W. B.; Peters, M.; Westwood, M.; Perkins, F. J. (1975). „Response to influenza vaccine in adjuvant 65-4”. The Journal of Hygiene. 74 (2): 251—259. PMC 2130368 . PMID 1054729. doi:10.1017/S0022172400024323.
Guimarães, L. E.; Baker, B.; Perricone, C.; Shoenfeld, Y. (2015). „Vaccines, adjuvants and autoimmunity”. Pharmacological Research. 100: 190—209. PMID 26275795. doi:10.1016/j.phrs.2015.08.003. Грешка код цитирања: Неисправна ознака <ref>; назив „:22” је дефинисано више пута с различитим садржајем
Apostólico, Juliana de Souza; Lunardelli, Victória Alves Santos; Coirada, Fernanda Caroline; Boscardin, Silvia Beatriz; Rosa, Daniela Santoro (2016). „Adjuvants: Classification, Modus Operandi , and Licensing”. Journal of Immunology Research. 2016: 1—16. PMC 4870346 . PMID 27274998. doi:10.1155/2016/1459394 .
Hutchison, Sharon; Benson, Robert A.; Gibson, Vivienne B.; Pollock, Abigail H.; Garside, Paul; Brewer, James M. (2012). „Antigen depot is not required for alum adjuvanticity”. The FASEB Journal. 26 (3): 1272—1279. PMC 3289510 . PMID 22106367. doi:10.1096/fj.11-184556.
Apostólico Jde, S.; Lunardelli, V. A.; Coirada, F. C.; Boscardin, S. B.; Rosa, D. S. (2016). „Adjuvants: Classification, Modus Operandi, and Licensing”. Journal of Immunology Research. 2016: 1—16. PMC 4870346 . PMID 27274998. doi:10.1155/2016/1459394 .
Alving, Carl R.; Beck, Zoltan; Matyas, Gary R.; Rao, Mangala (2016). „Liposomal adjuvants for human vaccines”. Expert Opinion on Drug Delivery. 13 (6): 807—816. PMID 26866300. S2CID 30639153. doi:10.1517/17425247.2016.1151871.

semanticscholar.org

api.semanticscholar.org

Guy, B. (2007). „The perfect mix: Recent progress in adjuvant research”. Nat Rev Microbiol. 5 (7): 505—17. PMID 17558426. S2CID 25647540. doi:10.1038/nrmicro1681. .
Reed, Steven G.; Orr, Mark T.; Fox, Christopher B. (2013). „Key roles of adjuvants in modern vaccines”. Nat Med. 19 (12): 1597—608. PMID 24309663. S2CID 5360604. doi:10.1038/nm.3409. .
Oteros, J.; Bartusel, E.; Alessandrini, F.; Núñez, A.; Moreno, D. A.; Behrendt, H.; Schmidt-Weber, C.; Traidl-Hoffmann, C.; Buters, J. (2019). „Artemisia pollen is the main vector for airborne endotoxin”. Journal of Allergy and Clinical Immunology. 143 (1): 367—377. PMID 30012513. S2CID 51645690. doi:10.1016/j.jaci.2018.05.040.
Oteros, J.; Bartusel, E.; Alessandrini, F.; Núñez, A.; Moreno, D. A.; Behrendt, H.; Schmidt-Weber, C.; Traidl-Hoffmann, C.; Buters, J. (2019). „Artemisia pollen is the main vector for airborne endotoxin”. Journal of Allergy and Clinical Immunology. 143 (1): 367—377. PMID 30012513. S2CID 51645690. doi:10.1016/j.jaci.2018.05.040. .
Alving, Carl R.; Beck, Zoltan; Matyas, Gary R.; Rao, Mangala (2016). „Liposomal adjuvants for human vaccines”. Expert Opinion on Drug Delivery. 13 (6): 807—816. PMID 26866300. S2CID 30639153. doi:10.1517/17425247.2016.1151871.

superbabyonline.com

„Immunization schedule in India 2020”. SuperBaby (на језику: енглески). 2020-06-23. Приступљено 2022-01-24.

worldcat.org

Yamamoto, Rokuro (1924). „Sur les bases nouvelles de la sismophysique et sur la constitution interne du globe terrestre”. Annales de Physique. 10 (1): 293—345. ISSN 0003-4169. doi:10.1051/anphys/192410010293.
Nguyen-Contant, Phuong; Sangster, Mark Y.; Topham, David J. (2021-03-17). „Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response”. Pathogens (Basel, Switzerland). 10 (3): 355. ISSN 2076-0817. doi:10.3390/pathogens10030355 .